By Sahru Keiser, BCAction Education and Mobilization Coordinator
How the heck does the Food and Drug Administration (FDA) decide whether a new breast cancer treatment or diagnostic tool is safe and effective? Why are new drugs and devices not necessarily better than old ones? What does it mean for a drug to get “accelerated approval,” and is this a good thing? And if a new medical product has benefits that outweigh the risks, does that mean the product is a good idea for you?
We hear these great questions often – so we’re offering a free webinar about the FDA’s drug approval process to answer these questions and more.
Register for upcoming webinar, FDA Approval: Who’s Being Harmed and Who’s Being Helped? ; we’re offering the webinar at two different times for your convenience:
The FDA approves a few dozen new drugs every year, but approximately 5,000 new medical devices, such as breast and other implants, mammography and MRI machines, radiation therapies, and infusion devices. Prescription drugs are tested in clinical trials, but almost all devices are approved through a “quick and easy” process that usually doesn’t require any testing to prove that these medical devices are safe or effective. As a result, some of these devices are neither safe nor effective!
Join us and special guest Dr. Diana Zuckerman, President of the Cancer Prevention and Treatment Fund of the National Research Center for Women & Families, to discuss the FDA drug and medical devices approval process and ways you can get involved to ensure that patient interests come first at the FDA.
Can’t make these times? No worries; register at either of the links above, and after the webinar is complete we’ll send you the recording so you can tune in whenever is convenient for you.
I look forward to “seeing” you at our next webinar!